BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38113113)

  • 1. Noncoding SNPs decrease expression of FABP5 during COPD exacerbations.
    El Kharbili M; Sasse SK; Sanford L; Jacobson S; Aviszus K; Gupta A; Guo C; Majka SM; Dowell RD; Gerber AN; Bowler RP; Gally F
    J Clin Invest; 2023 Dec; 134(3):. PubMed ID: 38113113
    [No Abstract]   [Full Text] [Related]  

  • 2. Cigarette smoke decreases airway epithelial FABP5 expression and promotes Pseudomonas aeruginosa infection.
    Gally F; Chu HW; Bowler RP
    PLoS One; 2013; 8(1):e51784. PubMed ID: 23349676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage programming is regulated by a cooperative interaction between fatty acid binding protein 5 and peroxisome proliferator-activated receptor γ.
    El Kharbili M; Aviszus K; Sasse SK; Zhao X; Serban KA; Majka SM; Gerber AN; Gally F
    FASEB J; 2022 May; 36(5):e22300. PubMed ID: 35436029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette smoke inhibits LPS-induced FABP5 expression by preventing c-Jun binding to the FABP5 promoter.
    Rao D; Perraud AL; Schmitz C; Gally F
    PLoS One; 2017; 12(5):e0178021. PubMed ID: 28542209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of epidermal fatty acid binding protein on 2D-NMR-assessed atherogenic dyslipidemia and related disorders.
    Ibarretxe D; Girona J; Amigó N; Plana N; Ferré R; Guaita S; Mallol R; Heras M; Masana L
    J Clin Lipidol; 2016; 10(2):330-8.e2. PubMed ID: 27055964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four SNPs and Systemic Level of FOXP3 in Smokers and Patients with Chronic Obstructive Pulmonary Disease.
    Chu S; Zhong X; Zhang J; Lai X; Xie J; Li Y
    COPD; 2016 Dec; 13(6):760-766. PubMed ID: 27310557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease.
    Weidner J; Jarenbäck L; de Jong K; Vonk JM; van den Berge M; Brandsma CA; Boezen HM; Sin D; Bossé Y; Nickle D; Ankerst J; Bjermer L; Postma DS; Faiz A; Tufvesson E
    Respir Res; 2017 May; 18(1):77. PubMed ID: 28464818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphic variation in surfactant protein B is associated with COPD exacerbations.
    Foreman MG; DeMeo DL; Hersh CP; Carey VJ; Fan VS; Reilly JJ; Shapiro SD; Silverman EK
    Eur Respir J; 2008 Oct; 32(4):938-44. PubMed ID: 18550614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High body mass index and risk of exacerbations and pneumonias in individuals with chronic obstructive pulmonary disease: observational and genetic risk estimates from the Copenhagen General Population Study.
    Çolak Y; Afzal S; Lange P; Nordestgaard BG
    Int J Epidemiol; 2016 Oct; 45(5):1551-1559. PubMed ID: 27118560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of SIGLEC9 polymorphisms on COPD phenotypes including exacerbation frequency.
    Ishii T; Angata T; Wan ES; Cho MH; Motegi T; Gao C; Ohtsubo K; Kitazume S; Gemma A; ParÉ PD; Lomas DA; Silverman EK; Taniguchi N; Kida K
    Respirology; 2017 May; 22(4):684-690. PubMed ID: 27878892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRDM15 Is Associated with Risk of Chronic Obstructive Pulmonary Disease in a Rural Population in Chile.
    Hosgood Iii HD; Díaz-Peña R; Blansky D; Jaime S; Parra V; Boekstegers F; Bermejo JL; García-Valero J; Montes JF; Valdivia G; Miravitlles M; Agustí À; Silva RS; Olloquequi J
    Respiration; 2020; 99(4):307-315. PubMed ID: 32222710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-Based Genetic Association Study Identifies CELSR1 as a Possible Chronic Obstructive Pulmonary Disease Risk Locus among Women.
    Hardin M; Cho MH; Sharma S; Glass K; Castaldi PJ; McDonald ML; Aschard H; Senter-Sylvia J; Tantisira K; Weiss ST; Hersh CP; Morrow JD; Lomas D; Agusti A; Bakke P; Gulsvik A; O'Connor GT; Dupuis J; Hokanson J; Crapo JD; Beaty TH; Laird N; Silverman EK; DeMeo DL;
    Am J Respir Cell Mol Biol; 2017 Mar; 56(3):332-341. PubMed ID: 27854507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The correlation between CYP4F2 variants and chronic obstructive pulmonary disease risk in Hainan Han population.
    Ding Y; Yang Y; Li Q; Feng Q; Xu D; Wu C; Zhao J; Zhou X; Niu H; He P; Liu J; Yao H
    Respir Res; 2020 Apr; 21(1):86. PubMed ID: 32295578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between TLR2/TLR4 gene polymorphisms and COPD phenotype in a Greek cohort.
    Apostolou A; Kerenidi T; Michopoulos A; Gourgoulianis KI; Noutsias M; Germenis AE; Speletas M
    Herz; 2017 Dec; 42(8):752-757. PubMed ID: 27909766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant protein D as a biomarker for chronic obstructive pulmonary disease.
    Bowler RP
    COPD; 2012 Dec; 9(6):651-3. PubMed ID: 23244171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of club cell secretory protein (CC-16) on COPD risk and progression: a Mendelian randomisation study.
    Milne S; Li X; Hernandez Cordero AI; Yang CX; Cho MH; Beaty TH; Ruczinski I; Hansel NN; Bossé Y; Brandsma CA; Sin DD; Obeidat M
    Thorax; 2020 Nov; 75(11):934-943. PubMed ID: 32839289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of fatty acid binding protein 5-deficiency on COPD exacerbations and cigarette smoke-induced inflammatory response to bacterial infection.
    Rao DM; Phan DT; Choo MJ; Weaver MR; Oberley-Deegan RE; Bowler RP; Gally F
    Clin Transl Med; 2019 Mar; 8(1):7. PubMed ID: 30877402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FABP5 is correlated with poor prognosis and promotes tumour cell growth and metastasis in clear cell renal cell carcinoma.
    Wu G; Xu Y; Wang Q; Li J; Li L; Han C; Xia Q
    Eur J Pharmacol; 2019 Nov; 862():172637. PubMed ID: 31491402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of sputum gene expression in chronic obstructive pulmonary disease.
    Qiu W; Cho MH; Riley JH; Anderson WH; Singh D; Bakke P; Gulsvik A; Litonjua AA; Lomas DA; Crapo JD; Beaty TH; Celli BR; Rennard S; Tal-Singer R; Fox SM; Silverman EK; Hersh CP;
    PLoS One; 2011; 6(9):e24395. PubMed ID: 21949713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor-9 polymorphisms in sarcoidosis and chronic obstructive pulmonary disease.
    Pabst S; Bradler O; Gillissen A; Nickenig G; Skowasch D; Grohe C
    Adv Exp Med Biol; 2013; 756():239-45. PubMed ID: 22836641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.